Patent · US Expired

Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them

US6924285B2 · kind B2 · utility

32Cited by

2References

9Claims

0Family size

Assignee

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

Frank Himmelsbach · Mittelbiberach, DE
Birgit Jung · Laupheim, DE
Flavio Solca · Wien, AT

Key dates

Filing date	Mar 27, 2003
Grant date	Aug 2, 2005
Priority date	—
Expiry date	Apr 13, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to bicyclic heterocyclic groups of general formula whereinRa, Rb, Rc, Rd and X are defined as in claim 1, the tautomers, the stereoisomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids which have valuable pharmacological properties, particularly an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases, as well as benign prostate hyperplasia (BPH), diseases of the lungs and respiratory tract, and the preparation thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.